Biopeak Secures Repeat Investment from Nikhil Kamath to Scale Longevity Care

• Biopeak, India’s first longevity and health optimisation brand, raised $2.7 million in its latest funding round.
• The investment was led by repeat investor Nikhil Kamath, signaling strong confidence in Biopeak's model.
• The company focuses on building structured, preventive care systems for longevity in India, addressing gaps in acute care.
• Funds will expand Biopeak’s presence, deepen capabilities in AI, diagnostics, and research, and launch a new flagship center in Bengaluru.
• Biopeak's approach combines diagnostics, AI-driven insights, clinical interventions, and sustained follow-up tailored for Indian health profiles.

Why It Matters: Biopeak secured $2.7 million from Nikhil Kamath to expand its AI-driven longevity and preventive healthcare services in India.